AB-PICA

From WikiMD's Wellness Encyclopedia

Revision as of 21:25, 11 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

AB-PICA

AB-PICA is a synthetic cannabinoid that has been used in scientific research. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system. AB-PICA is structurally related to other synthetic cannabinoids and is often used in studies to understand the effects of cannabinoids on the human body.

Chemical Structure

The chemical structure of AB-PICA is characterized by a core indole structure with a pentyl chain and an amide linkage. The full chemical name is N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide. This structure allows it to bind effectively to cannabinoid receptors, mimicking the effects of naturally occurring cannabinoids such as tetrahydrocannabinol (THC).

Chemical structure of AB-PICA

Pharmacology

AB-PICA acts as a full agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the G protein-coupled receptor family and are involved in a variety of physiological processes including pain sensation, mood regulation, and appetite.

The binding affinity of AB-PICA to these receptors is high, which contributes to its potent effects. The activation of CB1 receptors in the central nervous system is primarily responsible for the psychoactive effects associated with cannabinoids.

Legal Status

The legal status of AB-PICA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. It is often included in legislation aimed at controlling synthetic cannabinoids and other novel psychoactive substances.

Research and Applications

AB-PICA is primarily used in research settings to study the effects of synthetic cannabinoids on the body. It is used to investigate the endocannabinoid system and to develop potential therapeutic agents that target cannabinoid receptors.

Research involving AB-PICA can provide insights into the treatment of conditions such as chronic pain, multiple sclerosis, and epilepsy, where modulation of the endocannabinoid system may be beneficial.

Related Pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD weight loss doctors team
W8MD weight loss doctors team

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

NYC weight loss doctor appointmentsNYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Linkedin_Shiny_Icon Facebook_Shiny_Icon YouTube_icon_(2011-2013) Google plus


Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.